Atorvastatin Three Year Pediatric Study



Status:Completed
Conditions:High Cholesterol
Therapuetic Areas:Cardiology / Vascular Diseases
Healthy:No
Age Range:6 - 15
Updated:11/23/2013
Start Date:March 2009
End Date:October 2013
Contact:Pfizer CT.gov Call Center
Phone:1-800-718-1021

Use our guide to learn which trials are right for you!

A Three Year, Prospective, Open-Label, Study To Evaluate Clinical Efficacy, Safety And Tolerability Of Atorvastatin In Children And Adolescents With Heterozygous Familial Hypercholesterolemia


The purpose of this study is to characterize three year descriptive growth and development
(ie, height, weight, body mass index, Tanner Stage) and efficacy of cholesterol reduction
in pediatric subjects with Heterozygous Familial Hypercholesterolemia receiving atorvastatin
treatment.


Inclusion Criteria:

- Heterozygous familial hypercholesterolemia, ages 6-15, LDL greater than 4 mmol/l

Exclusion Criteria:

- Active liver disease or hepatic dysfunction, or persistent elevations of serum
transaminases exceeding three times the upper limit of normal (ULN).

Female of childbearing potential who is not using adequate contraceptive measures or any
female who is pregnant or breastfeeding. Any female who becomes pregnant during study
participation will be immediately discontinued from treatment and counseled appropriately
about the in utero exposure.

Known hypersensitivities to HMG-CoA reductase inhibitors
We found this trial at
6
sites
Pittsburgh, Pennsylvania 15212
?
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Akron, Ohio 44314
?
mi
from
Akron, OH
Click here to add this to my saved trials
Atlantis, Florida 33462
?
mi
from
Atlantis, FL
Click here to add this to my saved trials
Baltimore, Maryland 21234
?
mi
from
Baltimore, MD
Click here to add this to my saved trials
Gilbert, Arizona 85234
?
mi
from
Gilbert, AZ
Click here to add this to my saved trials
Washington, District of Columbia 20003
?
mi
from
Washington,
Click here to add this to my saved trials